310 related articles for article (PubMed ID: 20059664)
1. Genetic polymorphisms of 17 β-hydroxysteroid dehydrogenase 3 and the risk of hypospadias.
Sata F; Kurahashi N; Ban S; Moriya K; Tanaka KD; Ishizuka M; Nakao H; Yahata Y; Imai H; Kakizaki H; Nonomura K; Kishi R
J Sex Med; 2010 Aug; 7(8):2729-38. PubMed ID: 20059664
[TBL] [Abstract][Full Text] [Related]
2. The valine allele of the V89L polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadias.
Thai HT; Kalbasi M; Lagerstedt K; Frisén L; Kockum I; Nordenskjöld A
J Clin Endocrinol Metab; 2005 Dec; 90(12):6695-8. PubMed ID: 16174723
[TBL] [Abstract][Full Text] [Related]
3. Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children.
Samtani R; Bajpai M; Vashisht K; Ghosh PK; Saraswathy KN
J Urol; 2011 Jun; 185(6):2334-9. PubMed ID: 21511288
[TBL] [Abstract][Full Text] [Related]
4. Steroid 5-alpha-reductase type 2 (SRD5A2) gene V89L polymorphism and hypospadias risk: A meta-analysis.
Zhang K; Li Y; Mao Y; Ma M
J Pediatr Urol; 2017 Dec; 13(6):630.e1-630.e9. PubMed ID: 28713005
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
6. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.
Rahimi M; Ghanbari M; Fazeli Z; Rouzrokh M; Omrani S; Mirfakhraie R; Omrani MD
J Endocrinol Invest; 2017 Apr; 40(4):391-396. PubMed ID: 27848231
[TBL] [Abstract][Full Text] [Related]
7. Hypospadias and variants in genes related to sex hormone biosynthesis and metabolism.
Carmichael SL; Witte JS; Ma C; Lammer EJ; Shaw GM
Andrology; 2014 Jan; 2(1):130-7. PubMed ID: 24281767
[TBL] [Abstract][Full Text] [Related]
8. Association between
Sun L; Zhou M; Liu T
Pharmazie; 2019 Feb; 74(2):125-128. PubMed ID: 30782264
[TBL] [Abstract][Full Text] [Related]
9. The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred.
Can S; Zhu YS; Cai LQ; Ling Q; Katz MD; Akgun S; Shackleton CH; Imperato-McGinley J
J Clin Endocrinol Metab; 1998 Feb; 83(2):560-9. PubMed ID: 9467575
[TBL] [Abstract][Full Text] [Related]
10. Biochemical Analysis of Four Missense Mutations in the HSD17B3 Gene Associated With 46,XY Disorders of Sex Development in Egyptian Patients.
Engeli RT; Tsachaki M; Hassan HA; Sager CP; Essawi ML; Gad YZ; Kamel AK; Mazen I; Odermatt A
J Sex Med; 2017 Sep; 14(9):1165-1174. PubMed ID: 28859874
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation and identification of two novel SRD5A2 mutations in 33 Chinese patients with hypospadias.
Yuan S; Meng L; Zhang Y; Tu C; Du J; Li W; Liang P; Lu G; Tan YQ
Steroids; 2017 Sep; 125():61-66. PubMed ID: 28663096
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
Li X; Huang Y; Fu X; Chen C; Zhang D; Yan L; Xie Y; Mao Y; Li Y
Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
[TBL] [Abstract][Full Text] [Related]
13. Association of a tagging single nucleotide polymorphism in the androgen receptor gene region with susceptibility to severe hypospadias in a Caucasian population.
Adamovic T; Thai HT; Liedén A; Nordenskjöld A
Sex Dev; 2013; 7(4):173-9. PubMed ID: 23571770
[TBL] [Abstract][Full Text] [Related]
14. Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis.
Zhang D; Li Q; Qu HC; Yu T; Liu YR
Genet Mol Res; 2015 Aug; 14(3):9004-12. PubMed ID: 26345832
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias.
Wang R; Dong Z; Wang W; Xiao Y; Ni J; Wang D
J Pediatr Endocrinol Metab; 2013; 26(9-10):887-93. PubMed ID: 23729601
[TBL] [Abstract][Full Text] [Related]
16. Expression of Xenobiotic Biomarkers CYP1 Family in Preputial Tissue of Patients with Hypospadias and Phimosis and Its Association with DNA Methylation Level of SRD5A2 Minimal Promoter.
Ohsako S; Aiba T; Miyado M; Fukami M; Ogata T; Hayashi Y; Mizuno K; Kojima Y
Arch Environ Contam Toxicol; 2018 Feb; 74(2):240-247. PubMed ID: 29080015
[TBL] [Abstract][Full Text] [Related]
17. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
[TBL] [Abstract][Full Text] [Related]
18. 46,XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency.
Mendonca BB; Gomes NL; Costa EM; Inacio M; Martin RM; Nishi MY; Carvalho FM; Tibor FD; Domenice S
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):79-85. PubMed ID: 27163392
[TBL] [Abstract][Full Text] [Related]
19. Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation?
van der Zanden LF; van Rooij IA; Feitz WF; Vermeulen SH; Kiemeney LA; Knoers NV; Roeleveld N; Franke B
J Clin Endocrinol Metab; 2010 May; 95(5):2384-90. PubMed ID: 20215396
[TBL] [Abstract][Full Text] [Related]
20. CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.
Sobti RC; Onsory K; Al-Badran AI; Kaur P; Watanabe M; Krishan A; Mohan H
DNA Cell Biol; 2006 May; 25(5):287-94. PubMed ID: 16716118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
